Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-11-08

FDA Approved: TEGRETOL — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approves a supplemental application for Tegretol (carbamazepine) submitted by Novartis Pharmaceuticals Corporation, resulting in an updated labeling for the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TEGRETOL (CARBAMAZEPINE)

Snippet

SUPPL AP for TEGRETOL (CARBAMAZEPINE)